- Home
- CDTX vs CSAN Comparison
CDTX vs CSAN Comparison
Compare CDTX & CSAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- CSAN
- Stock Information
- Founded
- CDTX 2012
- CSAN 1936
- Country
- CDTX United States
- CSAN Brazil
- Employees
- CDTX 73
- CSAN N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- CSAN Retail-Auto Dealers and Gas Stations
- Sector
- CDTX Health Care
- CSAN Consumer Discretionary
- Exchange
- CDTX Nasdaq
- CSAN Nasdaq
- Market Cap
- CDTX 1.6B
- CSAN 2.0B
- IPO Year
- CDTX 2015
- CSAN N/A
- Fundamental
- Price
- CDTX $65.32
- CSAN $5.51
- Analyst Decision
- CDTX Strong Buy
- CSAN Buy
- Analyst Count
- CDTX 11
- CSAN 2
- Target Price
- CDTX $57.00
- CSAN $12.00
- AVG Volume (30 Days)
- CDTX 489.9K
- CSAN 1.8M
- Earning Date
- CDTX 11-06-2025
- CSAN 08-14-2025
- Dividend Yield
- CDTX N/A
- CSAN N/A
- EPS Growth
- CDTX N/A
- CSAN N/A
- EPS
- CDTX N/A
- CSAN N/A
- Revenue
- CDTX N/A
- CSAN $7,993,490,490.00
- Revenue This Year
- CDTX N/A
- CSAN $271.59
- Revenue Next Year
- CDTX N/A
- CSAN $1.72
- P/E Ratio
- CDTX N/A
- CSAN N/A
- Revenue Growth
- CDTX N/A
- CSAN 7.98
- 52 Week Low
- CDTX $10.14
- CSAN $3.80
- 52 Week High
- CDTX $69.36
- CSAN $10.12
- Technical
- Relative Strength Index (RSI)
- CDTX 58.07
- CSAN 72.38
- Support Level
- CDTX $61.10
- CSAN $5.20
- Resistance Level
- CDTX $65.84
- CSAN $5.53
- Average True Range (ATR)
- CDTX 3.05
- CSAN 0.19
- MACD
- CDTX -0.42
- CSAN 0.14
- Stochastic Oscillator
- CDTX 71.23
- CSAN 96.64
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About CSAN Cosan S.A. ADS
Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.